Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review
Crossref DOI link: https://doi.org/10.1186/s13046-015-0207-9
Published Online: 2015-09-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sherwood, James
Dearden, Simon
Ratcliffe, Marianne
Walker, Jill
Funding for this research was provided by:
AstraZeneca (GB) (AstraZeneca)